Drugs Containing Excipient (Inactive Ingredient) POVIDONE K90

Branded drugs containing POVIDONE K90 excipient, and estimated key patent expiration / generic entry dates

Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
Genentech Inc	CELLCEPT	mycophenolate mofetil	0004-0260	POVIDONE K90
Wyeth Pharmaceuticals LLC a subsidiary of Pfizer Inc	PROTONIX	pantoprazole sodium	0008-0843	POVIDONE K90
Novo Nordisk	RYBELSUS	oral semaglutide	0169-4303	POVIDONE K90	2033-03-15
AQUESTIVE THERAPEUTICS	LIBERVANT	diazepam	10094-305	POVIDONE K90
STAT RX USA LLC	PROTONIX	pantoprazole sodium	16590-939	POVIDONE K90

Generic drugs containing POVIDONE K90 excipient

Company	Ingredient	NDC	Excipient
Genentech Inc	mycophenolate mofetil	0004-0260	POVIDONE K90
Wyeth Pharmaceuticals LLC a subsidiary of Pfizer Inc	pantoprazole sodium	0008-0843	POVIDONE K90
Hikma Pharmaceuticals USA Inc	bexarotene	0054-0399	POVIDONE K90
Hikma Pharmaceuticals USA Inc	vigabatrin	0054-0652	POVIDONE K90
Teva Pharmaceuticals USA, Inc.	diltiazem hydrochloride	0093-0318	POVIDONE K90

POVIDONE K90 Market Analysis and Financial Projection

Last updated: February 8, 2026

Market Dynamics and Financial Trajectory for POVIDONE K90

Overview

POVIDONE K90, a high molecular weight grade of polyvinylpyrrolidone (PVP), functions primarily as a binder, stabilizer, and solubility enhancer in pharmaceutical formulations. It holds a significant position in the excipient market due to its compatibility, safety profile, and versatile applications. Market trends indicate a steady growth trajectory driven by expanding pharmaceutical R&D, increasing biosimilar development, and rising demand for advanced drug delivery systems.

Market Size and Forecast

Current Market Size

Global POVIDONE K90 market was valued at approximately $250 million in 2022. This figure encompasses manufacturing, research, and application segments across continents.

Growth Projections

The compound annual growth rate (CAGR) for the POVIDONE K90 segment is projected at 6% from 2023 to 2030. The forecast estimates a market size exceeding $400 million by 2030, driven by increased pharmaceutical production and evolving formulation technologies.

Year	Market Size (USD Million)	CAGR (%)
2022	250	—
2025	320	7
2030	410	6

Regional Breakdown

• Asia-Pacific: Dominates with over 50% market share, driven by China and India’s booming pharmaceutical and excipient manufacturing sectors.
• North America: Accounts for around 25%, with growth linked to biopharmaceutical R&D and generic drug production.
• Europe: Holds approximately 15%, with increasing focus on advanced drug formulations.

Drivers and Restraints

Drivers

• Growing pharmaceutical R&D activities, especially in biologics and biosimilars, necessitate reliable excipients like POVIDONE K90.
• Regulatory compliance fostering demand for proven, safe excipients.
• Technological advances that optimize drug delivery, such as controlled release systems, incorporate POVIDONE K90 for its binding properties.
• Expansion in generic and OTC drug markets expands POVIDONE K90 applications.

Restraints

• Fluctuations in raw material costs, notably monomer and solvent supply.
• Stringent regulations in certain regions (e.g., Europe’s EMA guidelines) can delay product approvals.
• Market entry barriers due to proprietary formulations and patents held by major suppliers.

Competitive Landscape

Major manufacturers include:

• BASF SE
• Ashland Global Holdings Inc.
• International Speciality Products (ISP)
• Meggle Group
• Nippon Shokubai Co., Ltd.

Concentration is high; top three players control approximately 70% of production capacity. Companies invest heavily in R&D for high-purity or specific-grade POVIDONE variants tailored to niche pharmaceutical needs.

Pricing Trends

Pricing for POVIDONE K90 is sensitive to raw material prices and manufacturing economies. In 2022, the average price ranged from $5.00 to $7.50 per kg. Price stability is challenged by supply chain disruptions, but economies of scale support gradual price reductions for bulk orders. Custom grades or high-purity specifications command premiums.

Innovation and R&D Trends

• Development of POVIDONE K90 derivatives with enhanced binding and solubility traits.
• Integration into nanotechnology-based drug delivery systems to improve bioavailability.
• Efforts to reduce manufacturing costs and environmental footprint.

Regulatory Environment

• US FDA and EMA classify POVIDONE as Generally Recognized As Safe (GRAS) and suitable for pharmaceutical use.
• International pharmacopeias (USP, EP, JP) specify grades and purity standards for excipient inclusion.
• Close monitoring of impurity profiles is essential for compliance, especially for high-potency formulations.

Investment Outlook

• Entry barriers remain due to established supplier dominance.
• Opportunities exist in developing specialty grades or environmentally sustainable manufacturing processes.
• Mergers and acquisitions are common, aiming to consolidate supply chains and expand product portfolios.

Key Takeaways

1. The POVIDONE K90 market exhibits steady growth, fueled by pharmaceutical R&D and evolving drug delivery technologies.
2. Asia-Pacific dominates the market, but North America and Europe present expanding opportunities.
3. Capital investments in R&D for novel derivatives and high-purity grades are critical for market leaders.
4. Price volatility aligns with raw material costs and global supply chain dynamics.
5. Regulatory compliance remains a key consideration for new entrants and product development.

FAQs

What factors influence POVIDONE K90 pricing?
Raw material costs, manufacturing scale, purity specifications, and supply chain logistics.

How is POVIDONE K90 used in pharmaceutical formulations?
Primarily as a binder in tablet manufacturing, a stabilizer in suspensions, and a solubility enhancer.

What regulatory standards govern POVIDONE K90?
US FDA, EMA, USP, EP, and JP pharmacopeias specify requirements for purity, specifications, and safety.

Are there environmental concerns associated with POVIDONE K90 production?
Manufacturing involves solvent use and waste management, prompting innovations in green chemistry.

What emerging applications could impact future demand?
Nanotechnology drug delivery, biosimilars, and sustained-release formulations.

---

References

1. MarketsandMarkets. “Polyvinylpyrrolidone Market by Grade, Application, and Region — Global Forecast to 2027.”
2. Grand View Research. “Pharmaceutical Excipient Market Size, Share & Trends Analysis Report.”
3. U.S. Pharmacopeia. “Monograph for Povidone (Polyvinylpyrrolidone).”
4. Industry reports from BASF, Ashland, and Nippon Shokubai.